Vitamin D and energy homeostasis - Of mice and men

Nature Reviews Endocrinology

Volumn 10, Issue 2, 2014, Pages 79-87

  Bouillon, Roger ^a   Carmeliet, Geert ^a   Lieben, Liesbet ^a   Watanabe, Mitsuhiro ^b   Perino, Alessia ^c   Auwerx, Johan ^c   Schoonjans, Kristina ^c   Verstuyf, Annemieke ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KEIO UNIVERSITY   (Japan)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CALCIFEDIOL; CALCITRIOL; CELL NUCLEUS RECEPTOR; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOSE TISSUE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; ENERGY; ENERGY HOMEOSTASIS; ENERGY METABOLISM; EPIDEMIC; HOMEOSTASIS; HUMAN; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; TARGET ORGAN;

ADIPOGENESIS; ANIMALS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MICE; OBESITY; VITAMIN D;

EID: 84892999166     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.226     Document Type: Review

References (102)

1. Van Belle, T. L., Gysemans, C. & Mathieu, C. Vitamin D and diabetes: The odd couple. Trends Endocrinol. Metab. http://dx.doi.org/10.1016/j.tem.2013. 07.002.
2. Bouillon, R. in Endocrinology Vol. 1 (eds Jameson, J. L. & De Groot, L. J.) 1089-1110 (Saunders Elsevier, Philadelphia, 2010).
3. Bouillon, R. et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776 (2008).
4. Bouillon, B., Lieben, L., Mathieu, C., Verstuyf, A. & Carmeliet, G. Vitamin D action: Lessons from VDR and Cyp27b1 null mice. Pediatric Endocrinol. Rev. 10 (Suppl. 2), 354-366 (2013).
5. Kriebitzsch, C. et al. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells - a microarray approach. Anticancer Res. 29, 3471-3483 (2009).
6. Carlberg, C., Seuter, S. & Heikkinen, S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 32, 271-282 (2012).
7. Pike, J. W. & Meyer, M. B. The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum. Dis. Clin. North Am. 38, 13-27 (2012).
8. Rosen, C. J. et al. The nonskeletal effects of vitamin D: An Endocrine Society scientific statement. Endocr. Rev. 33, 456-492 (2012).
9. Ahmadian, M. et al. PPAR signaling and metabolism: The good, the bad and the future. Nat. Med. 19, 557-566 (2013).
10. Mauvais-Jarvis, F. Estrogen and androgen receptors: Regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol. Metab. 22, 24-33 (2011).
11. Ding, C., Gao, D., Wilding, J., Trayhurn, P. & Bing, C. Vitamin D signalling in adipose tissue. Br. J. Nutr. 108, 1915-1923 (2012).
12. Lee, H., Bae, S. & Yoon, Y. Anti-adipogenic effects of 1,25-dihydroxyvitamin D3 are mediated by the maintenance of the wingless-type MMTV integration site/-catenin pathway. Int. J. Mol. Med. 30, 1219-1224 (2012).
13. Blumberg, J. M. et al. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J. Biol. Chem. 281, 11205-11213 (2006).
14. Narvaez, C. J. et al. Induction of STEAP4 correlates with 1 25-dihydroxyvitamin D stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J. Cell. Physiol. 228, 2024-2036 (2013).
15. Cianferotti, L. & Demay, M. B. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J. Cell. Biochem. 101, 80-88 (2007).
16. Nimitphong, H., Holick, M. F., Fried, S. K. & Lee, M. J. 25-hydroxyvitamin D3 and 1 25-dihydroxyvitamin D3 promote the differentiation of human subcutaneous preadipocytes. PLoS ONE 7, e52171 (2012).
17. Manna, P. & Jain, S. K. Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathioninelyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J. Biol. Chem. 287, 42324-42332 (2012).
18. Elbein, S. C. et al. Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. Diabetes 60, 1019-1029 (2011).
19. Sun, X., Morris, K. L. & Zemel, M. B. Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: A microarray study. J. Nutrigenet. Nutrigenomics 1, 30-48 (2008).
20. Malloy, P. J. & Feldman, B. J. Cell-autonomous regulation of brown fat identity gene UCP1 by unliganded vitamin D receptor. Mol. Endocrinol. 27, 1632-1642 (2013).
21. Kong, J., Chen, Y., Zhu, G., Zhao, Q. & Li, Y. C. 1,25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J. Endocrinol. 216, 265-271 (2013).
22. Craig, T. A. et al. Research resource: whole transcriptome RNA sequencing detects multiple 1, 25-dihydroxyvitamin D(3)-sensitive metabolic pathways in developing zebrafish. Mol. Endocrinol. 26, 1630-1642 (2012).
23. Bouillon, R. & Decallonne, B. The white adipose tissue connection with calcium and bone homeostasis. J. Bone Miner. Res. 25, 1707-1710 (2010).
24. Menendez, C. et al. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J. Endocrinol. 170, 425-431 (2001).
25. Breslavsky, A. et al. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin. Nutr. http://dx.doi.org/10.1016/j.clnu.2013.01.020.
26. Li, Y. C. et al. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl Acad. Sci. USA 94, 9831-9835 (1997).
27. Guzey, M. et al. Increased apoptosis of periprostatic adipose tissue in VDR null mice. J. Cell. Biochem. 93, 133-141 (2004).
28. Zinser, G. M. & Welsh, J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25, 2361-2372 (2004).
29. Welsh, J. et al. Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor. PLoS ONE 6, e16479 (2011).
30. Narvaez, C. J., Matthews, D., Broun, E., Chan, M. & Welsh, J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150, 651-661 (2009).
31. Weber, K. & Erben, R. G. Differences in triglyceride and cholesterol metabolism and resistance to obesity in male and female vitamin D receptor knockout mice. J. Anim. Physiol. Anim. Nutr. 4, 675-683 (2013).
32. Yamamoto, Y. et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 154, 1008-1020 (2013).
33. Wong, K. E. et al. Involvement of the vitamin D receptor in energy metabolism: Regulation of uncoupling proteins. Am. J. Physiol. Endocrinol. Metab. 296, E820-E828 (2009).
34. Shi, H., Norman, A. W., Okamura, W. H., Sen, A. & Zemel, M. B. 1,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J. 16, 1808-1810 (2002).
35. Wu, J., Cohen, P. & Spiegelman, B. M. Adaptive thermogenesis in adipocytes: Is beige the new brown Genes Dev. 27, 234-250 (2013).
36. Wong, K. E. et al. Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J. Biol. Chem. 286, 33804-33810 (2011).
37. Martens, K., Bottelbergs, A. & Baes, M. Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: Implications for metabolism research. FEBS Lett. 584, 1054-1058 (2010).
38. Steenbock, H. & Herting, D. C. Vitamin D and growth. J. Nutr. 57, 449-468 (1955).
39. Halloran, B. P. & DeLuca, H. F. Vitamin D deficiency and reproduction in rats. Science 204, 73-74 (1979).
40. Nyomba, B. L., Bouillon, R. & De Moor, P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115, 191-197 (1984).
41. Bhat, M., Kalam, R., Qadri, S. S., Madabushi, S. & Ismail, A. Vitamin D deficiency induced muscle wasting occurs through the ubiquitin proteasome pathway and is partially corrected by calcium in male rats. Endocrinology 154, 4018-4029 (2013).
42. Choi, M. et al. Vitamin D receptor activation induces peptide YY transcription in pancreatic islets. Endocrinology 153, 5188-5199 (2012).
43. Lancha, A., Frühbeck, G. & Gómez-Ambrosi, J. Peripheral signalling involved in energy homeostasis control. Nutr. Res. Rev. 25, 223-248 (2012).
44. Francis, G. A., Fayard, E., Picard, F. & Auwerx, J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65, 261-311 (2003).
45. Pearen, M. A. & Muscat, G. E. Orphan nuclear receptors and the regulation of nutrient metabolism: Understanding obesity. Physiology (Bethesda) 27, 156-166 (2012).
46. Mauvais-Jarvis, F., Cleqq, D. & Hevener, A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 34, 309-338 (2013).
47. Fan, W. et al. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54, 1000-1008 (2005).
48. Kersten, S. et al. Peroxisome proliferator-activated receptor mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498 (1999).
49. Deeb, S. S. et al. A Pro12Ala substitution in PPAR2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20, 284-287 (1998).
50. Tanaka, T. et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid -oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl Acad. Sci. USA 100, 15924-15929 (2003).
51. Evans, R. M., Barish, G. D. & Wang, Y. X. PPARs and the complex journey to obesity. Nat. Med. 10, 355-361 (2004).
52. Li, L. et al. The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell. Metab. 9, 77-87 (2009).
53. Zhang, Y. et al. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol. Endocrinol. 26, 272-280 (2012).
54. He, J. et al. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 62, 1876-1887 (2013).
55. Dong, B. et al. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc. Natl Acad. Sci. USA 106, 18831-18836 (2009).
56. Kalaany, N. Y. et al. LXRs regulate the balance between fat storage and oxidation. Cell. Metab. 1, 231-244 (2005).
57. Moreau, A., Maurel, P., Vilarem, M. J. & Pascussi, J. M. Constitutive androstane receptor-vitamin D receptor crosstalk: Consequence on CYP24 gene expression. Biochem. Biophys. Res. Commun. 360, 76-82 (2007).
58. Pols, T. W., Noriega, L. G., Nomura, M., Auwerx, J. & Schoonjans, K. The bile acid membrane receptor TGR5: A valuable metabolic target. Dig. Dis. 29, 37-44 (2011).
59. Harach, T. et al. TGR5 potentiates GLP1 secretion in response to anionic exchange resins. Sci. Rep. 2, 430 (2012).
60. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678-693 (2008).
61. Watanabe, M. et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J. Biol. Chem. 286, 26913-26920 (2011).
62. Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489 (2006).
63. Ockenga, J. et al. Plasma bile acids are associated with energy expenditure and thyroid function in humans. J. Clin. Endocrinol. Metab. 97, 535-542 (2012).
64. Svensson, P. A. et al. The TGR5 gene is expressed in human subcutaneous adipose tissue and is associated with obesity, weight loss and resting metabolic rate. Biochem. Biophys. Res. Commun. 433, 563-566 (2013).
65. Makishima, M. et al. Vitamin D receptor as an intestinal bile acid sensor. Science 296, 1313-1316 (2002).
66. Narisawa, T., Magadia, N. E., Weisburger, J. H. & Wynder, E. L. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of NmethylN'nitroN-nitrosoguanidine in rats. J. Natl Cancer Inst. 53, 1093-1097 (1974).
67. Bartik, L. et al. Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J. Nutr. Biochem. 21, 1153-1161 (2010).
68. Nehring, J. A., Zierold, C. & DeLuca, H. F. Lithocholic acid can carry out in vivo functions of vitamin D. Proc. Natl Acad. Sci. USA 104, 10006-10009 (2007).
69. Schmidt, D. R. et al. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem. 285, 14486-14494 (2010).
70. Han, S., Li, T., Ellis, E., Strom, S. & Chiang, J. Y. A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol. Endocrinol. 24, 1151-1164 (2010).
71. Yoshizawa, T. et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16, 391-396 (1997).
72. Sakakura, H. et al. Simultaneous determination of bile acids in rat bile and serum by high-performance liquid chromatography. J. Chromatogr. 621, 123-131 (1993).
73. Nishida, S., Ozeki, J. & Makishima, M. Modulation of bile acid metabolism by 1-hydroxyvitamin D3 administration in mice. Drug Metab. Dispos. 37, 2037-2044 (2009).
74. Mathieu, C., Gysemans, C., Giulietti, A. & Bouillon, R. Vitamin D and diabetes. Diabetologia 48, 1247-1257 (2005).
75. Hyppönen, E., Boucher, B. J., Berry, D. J. & Power, C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: A cross-sectional study in the 1958 British Birth Cohort. Diabetes 57, 298-305 (2008).
76. Earthman, C. P., Beckman, L. M., Masodkar, K. & Sibley, S. D. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: Considerations and implications. Int. J. Obes. (Lond.) 36, 387-396 (2012).
77. Vimaleswaran, K. S. et al. Causal relationship between obesity and vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 10, e1001383 (2013).
78. Soares, M. J., Chan She Ping-Delfos, W. & Ghanbari, M. H. Calcium and vitamin D for obesity: A review of randomized controlled trials. Eur. J. Clin. Nutr. 65, 994-1004 (2011).
79. Song, Q. & Sergeev, I. N. Calcium and vitamin D in obesity. Nutr. Res. Rev. 25, 130-141 (2012).
80. Davidson, M. B., Duran, P., Lee, M. L. & Friedman, T. C. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 36, 260-266 (2013).
81. Boon, N. et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 14, 1739-1746 (2006).
82. Kayaniyil, S. et al. Prospective association of 25(OH)D with metabolic syndrome. Clin. Endocrinol. (Oxf.) http://dx.doi.org/10.1111/cen.12190.
83. Auwerx, J., Bouillon, R. & Kesteloot, H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler. Thromb. 12, 671-674 (1992).
84. Song, Y. et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 36, 1422-1428 (2013).
85. Pittas, A. G. et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307-314 (2010).
86. Mitri, J., Muraru, M. D. & Pittas, A. G. Vitamin D and type 2 diabetes: A systematic review. Eur. J. Clin. Nutr. 65, 1005-1015 (2011).
87. von Hurst, P. R., Stonehouse, W. & Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br. J. Nutr. 103, 549-555 (2010).
88. Bouillon, R. Vitamin D as potential baseline therapy for blood pressure control. Am. J. Hypertens. 22, 816 (2009).
89. Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z. & Holick, M. F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 72, 690-693 (2000).
90. Drincic, A. T., Armas, L. A., Van Diest, E. E. & Heaney, R. P. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 20, 1444-1448 (2012).
91. Mason, C. et al. Effects of weight loss on serum vitamin D in postmenopausal women. Am. J. Clin. Nutr. 94, 95-103 (2011).
92. Gallagher, J. C., Peacock, M., Yalamanchili, V. & Smith, L. M. Effects of vitamin D supplementation in older African American women. J. Clin. Endocrinol. Metab. 98, 1137-1146 (2013).
93. Gallagher, J. C., Yalamanchili, V. & Smith, L. M. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J. Steroid Biochem. Mol. Biol. 136, 195-200 (2013).
94. Sinha, A., Hollingsworth, K. G., Ball, S. & Cheetham, T. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J. Clin. Endocrinol. Metab. 98, E509-E513 (2013).
95. Bouillon, R. & Verstuyf, A. Vitamin D, mitochondria, and muscle. J. Clin. Endocrinol. Metab. 98, 961-963 (2013).
96. Bal, N. C. et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nat. Med. 18, 1575-1579 (2012).
97. White, J. H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J. Steroid. Biochem. Mol. Biol. 121, 234-238 (2010).
98. Bal, B. S., Finelli, F. C., Shope, T. R. & Koch, T. R. Nutritional deficiencies after bariatric surgery. Nat. Rev. Endocrinol. 8, 544-556 (2012).
99. Pols, T. W. et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell. Metab. 14, 747-757 (2011).
100. Gascon-Barré, M. et al. The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37, 1034-1042 (2003).
101. Ding, N. et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613 (2013).
102. Watanabe, M. et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113, 1408-1418 (2004).